PCM
GRDN

Peregrine Capital Management’s Guardian Pharmacy Services GRDN Stock Holding History

Peregrine Capital Management’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.59M Sell
201,603
-19,453
-9% -$635K 0.28% 108
2025
Q4 		$6.65M Sell
221,056
-10,955
-5% -$310K 0.2% 139
2025
Q3 		$6.09M Buy
232,011
+17,632
+8% +$420K 0.18% 167
2025
Q2 		$4.57M Buy
214,379
+37,840
+21% +$854K 0.14% 222
2025
Q1 		$3.75M Buy
176,539
+63,464
+56% +$1.3M 0.12% 233
2024
Q4 		$2.29M Sell
113,075
-170,284
-60% -$3.52M 0.07% 249
2024
Q3 		$4.76M Buy
+283,359
New +$4.77M 0.14% 225

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VCM
Valiant Capital Management San Francisco, California $1.27B AUM 64.05% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return